Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Solicitation opportunity from Department Of Veterans Affairs was posted on June 26, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

6505--Fluorouracil RFP

Closed
36E79726R0024Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The Department of Veterans Affairs, through its National Acquisition Center, is soliciting bids for Fluorouracil 5% Cream under solicitation number 36E79726R0024, titled 6505--Fluorouracil RFP, in accordance with FAR Part 12 as a commercial item procurement. This unrestricted contract aims to secure an uninterrupted supply of 126,107 tubes of Fluorouracil 5% Cream, each containing 40 grams, for distribution to the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service through their respective Pharmaceutical Prime Vendor Programs. The contract term includes one base year and four pre-priced one-year option periods, with the requirement that all drug products must bear a unique NDC number and be labeled exactly as the name appears on the official product label. Glass packaging is strictly prohibited, and offerors must ensure compliance with these specifications to be considered. Proposals must be submitted electronically via SAM.gov by the deadline of June 22, 2026, at 2:30 p.m. Central Time, with no paper copies available or accepted. The award will be made to the responsible offeror capable of guaranteeing continuous, reliable supply, with no set-asides or preference programs applied. All inquiries should be directed to Contract Specialist Amber Zavala at amber.zavala@va.gov or (708) 786-5245, located at the VA office in Hines, Illinois, 60141. Offerors are advised to monitor the SAM.gov portal continuously for any amendments or updates to the solicitation.

General Info

VA seeks single contract for Fluorouracil 5% Cream, one-year plus four option periods.

Agency

Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)View Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

IL

Set-Aside

NONE

Documents

(3)

Solicitation 36E79726R0024 for Fluorouracil 5% Cream

DOCXrfq

RFP 36E79726R0024 Fluorouracil 5% Cream

DOCXrfp

Amendment 0001 to RFP 36E79726R0024 - Due Date Extension

DOCXamendment

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

1 update
PhaseClosed
Posted

Presolicitation

Type Changed

Presolicitation → Solicitation

Amendment 1

Contract was updated

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Veterans Affairs → Nac Pharmaceuticals (36E797)
Contacts1 person available
OfficeHINES, IL, 60141, USA
Organization / Agency
Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)
View Agency Profile
Office AddressHINES, IL, 60141, USA
Contacts
Amber ZavalaContract Specialist

Full Description

Show more
n/a

More opportunities from Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)

Same awarding agency

NAICS: 325412
New
Federal
6505--Ticagrelor Tablets
Solicitation # 36E79726R0028
The Department of Veterans Affairs National Acquisition Center is seeking an unrestricted procurement to establish an uninterrupted source of supply for Ticagrelor Tablets. This firm-fixed-price, indefinite-delivery requirements contract supports multiple federal health agencies, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The award is designated as a HUBZONE small business set-aside and will be granted to the lowest-priced, technically acceptable offeror. The contract structure consists of a base year and four one-year options, with a maximum 60-calendar day implementation period before the ordering period begins. The scope of work includes the supply of Ticagrelor in 60mg and 90mg strengths across various bottle sizes, ranging from 60 to 1,000 tablets. Strict packaging and labeling standards are required, including the use of cylindrical bottles with a minimum 120cc volume and 5.75 inch circumference, safety caps that are convertible or deshelled, and unique 11-digit NDC numbers. All products must be compatible with automated dispensing units and feature GS1-128 or HIBC linear bar codes, as well as two-dimensional data matrix bar codes per the Drug Supply Chain Security Act. To be eligible for award, offerors must maintain an acceptable FDA cGMP status for their manufacturing facilities and provide the necessary NDA, ANDA, or BLA clearances. Those who are not the manufacturer must provide a formal Letter of Commitment ensuring a sufficient source of supply. Distribution will be managed through Government Prime Vendor contracts, with deliveries made to approximately 56 VA and DoD distribution centers nationwide. Proposals must be submitted in PDF or Word format, including a signed SF-1449 and pricing for all line items across the base and option years, with prices held firm for 120 calendar days.
Pharmaceutical Preparation Manufacturing

POSTED

3 days ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
Federal
6505--2027-2028 Influenza Virus Vaccine
Solicitation # 36E79726R0035
Solicitation 36E79726R0035 is an unrestricted FAR Part 12 commercial-item procurement issued by the Department of Veterans Affairs National Acquisition Center for the supply of Influenza Virus Vaccines for the 2027-2028 season. The contract requires the delivery of trivalent or quadrivalent vaccines in pre-filled single-dose syringes with plunger and Luer lock needle attachments, provided in boxes of 10. The vaccines must be latex and preservative free, with specific FDA approval and labeling required for pediatric populations (6 to 35 months) and seniors (65 years and older). Final vaccine presentation is based on World Health Organization recommendations, with a preference for Trivalent presentations if both Trivalent and Quadrivalent options are commercially available. The award will be made on a per solicitation line item basis for the VA, Bureau of Prisons, Indian Health Service, and the Captain James A. Lovell Federal Health Care Center. Deliveries are Free On Board Destination to government facilities across the United States, Puerto Rico, and the Philippines. Most facilities require a two-part delivery schedule, with at least 50 percent of the order delivered between August 15 and September 15, 2027, and the remainder by October 15, 2027; however, the FHCC must receive 100 percent of its awarded quantity by September 15, 2027. Offerors must provide the full quantity for any line item bid, and final pricing must include the Cost Recovery Fee and Federal Excise Tax.
Pharmaceutical Preparation Manufacturing

POSTED

4 days ago

DEADLINE

in 12 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS